Who Owns Kailera Therapeutics Stock?
NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 93.65%
- Institutions (% of float)
- 103.20%
- Held by insiders
- 9.25%
- Institutional holders
- 177
- Institutions 90.7%
- Insiders 9.3%
- Public and other 0.0%
Who owns Kailera Therapeutics stock?
Institutional investors own about 93.6% of Kailera Therapeutics's shares, spread across 177 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 9.25% of KLRA.
The largest institutional holders are Bain Capital Investors Llc (20.22%), Bain Capital Life Sciences Investors, LLC (17.39%) and RTW Investments LP (8.30%). Together, the top 10 institutions control 70.3% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their KLRA positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KLRA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Bain Capital Investors Llc | 26.26M | 20.22% | +100.0% |
| Bain Capital Life Sciences Investors, LLC | 22.58M | 17.39% | +100.0% |
| RTW Investments LP | 10.78M | 8.30% | +100.0% |
| Canada Pension Plan Investment Board | 7.30M | 5.63% | +100.0% |
| Atlas Venture Life Science Advisors, LLC | 5.17M | 3.98% | 0.0% |
| FMR, LLC | 4.66M | 3.59% | +17.4% |
| Blackrock Inc. | 4.57M | 3.52% | +16.4% |
| Price (T.Rowe) Associates Inc | 3.53M | 2.72% | +100.0% |
| Citadel Advisors Llc | 3.24M | 2.50% | +100.0% |
| Adage Capital Partners GP L.L.C. | 3.21M | 2.47% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KLRA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 2.19M | 1.69% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.66M | 1.28% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.22M | 0.94% |
| iShares Trust-iShares Russell 2000 ETF | 1.20M | 0.92% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.18M | 0.91% |
| T. Rowe Price Health Sciences Fund, Inc. | 904.28K | 0.70% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 850.04K | 0.65% |
| Columbia Funds Series Trust I-Columbia Small Cap Growth Fund | 784.06K | 0.60% |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 761.69K | 0.59% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 700.90K | 0.54% |
Frequently asked questions
Who is the largest shareholder of Kailera Therapeutics?
Bain Capital Investors Llc is the largest institutional shareholder of KLRA, owning 20.22% of shares outstanding (26.26M shares) as of its latest 13F filing.
What percentage of Kailera Therapeutics is owned by institutions?
Institutions own about 93.6% of KLRA shares and 103.2% of the public float.
How much of Kailera Therapeutics do insiders own?
Insiders, such as officers and directors, own about 9.25% of KLRA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.